Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 22, 2021 - Issue sup1: Assessments of Pulmonary Function in patients with Amyotrophic Lateral Sclerosis: Options and Applicability in both the clinical care and clinical trial settings
Submit an article Journal homepage
2,554
Views
8
CrossRef citations to date
0
Altmetric
Research Articles

Pulmonary function decline in amyotrophic lateral sclerosis

Terry D. Heiman-Patterson1 Department of Neurology, Temple University Lewis Katz School of Medicine, Philadelphia, PAUSACorrespondence[email protected]
View further author information
,
Ossama Khazaal2 Department of Neurology, University of Pennsylvania, Philadelphia, PA, USAView further author information
,
Daohai Yu3 Department of Clinical Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USAView further author information
,
Michael E. Sherman4 Department of Medicine, MCG-Hearst Health, Drexel University College of Medicine, Philadelphia, PA, USAView further author information
,
Edward J. Kasarskis5 Department of Neurology, University of Kentucky, Lexington, KY, USA, andView further author information
,
Carlayne E. Jackson6 Department of Neurology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USAView further author information
& the PEG NIV study Group show all
Pages 54-61 | Received 04 Jan 2021, Accepted 22 Mar 2021, Published online: 04 Aug 2021

References

  • Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al.; Quality Standards Subcommittee of the American Academy of Neurology. Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2009;73:1218–26.
  • Lo Coco D, Marchese S, Pesco MC, La Bella V, Piccoli F, Lo Coco A, et al. Non-invasive positive-pressure ventilation in ALS: predictors of tolerance and survival. Neurology 2006;67:761–5.
  • Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999;164:82–8.
  • Aboussouan LS, Khan SU, Banerjee M, Arroliga AC, Mitsumoto H. Objective measures of the efficacy of noninvasive positive-pressure ventilation in ALS. Muscle Nerve. 2001;24:403–9.
  • Lyall RA, Donaldson N, Fleming T, Wood C, Newsom-Davis I, Polkey MI, et al. A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology. 2001;57:153–6.
  • Newsome-Davis IC, et al. The effect of noninvasive positive pressure ventilation (NIPPV) on cognitive function in ALS: a prospective study. J Neurol Neurosurg Psychiatry. 2001;71:482–7.
  • Martin S, Trevor-Jones E, Khan S, Shaw K, Marchment D, Kulka A, et al. The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:569–75.
  • Aboussouan LS, Mireles-Cabodevila E. Respiratory support in patients with amyotrophic lateral sclerosis. Respir Care. 2013;58:1555–8.
  • Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
  • Heiman-Patterson TD, Cudkowicz ME, De Carvalho M, Genge A, Hardiman O, Jackson CE, et al. Understanding the use of NIV in ALS: results of an international ALS specialist survey. Amyotroph Lateral Scler Frontotemporal Degener. 2018; 19:331–41.
  • Jacobs TL, Brown DL, Baek J, Migda EM, Funckes T, Gruis KL. Trial of early noninvasive ventilation for ALS: A pilot placebo-controlled study. Neurology 2016;87:1878–83.
  • Vitacca M, Montini A, Lunetta C, Banfi P, Bertella E, De Mattia E, et al.; ALS RESPILOM Study Group. Impact of an early respiratory care programme with non-invasive ventilation adaptation in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018;25:556–e33.
  • Noah L, et al. Respiratory measures in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis Frontotemporal Degen 2018;19:321–30.
  • Kasarskis EJ, Mendiondo MS, Wells S, Malguizo MS, Thompson M, Healey M, et al.; ALS Nutrition/NIPPV Study Group. The ALS Nutrition/NIPPV Study: design, feasibility, and initial results. Amyotroph Lateral Scler. 2011;12:17–25.
  • Jackson C, De Carvalho M, Genge A, Heiman-Patterson T, Shefner JM, Wei J, et al. Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R. Amyotrophic Lateral Sclerosis Frontotemporal Degen. 2018;19:506–12.
  • Polla B, D'Antona G, Bottinelli R, Reggiani C. Respiratory muscle fibres: specialisation and plasticity. Thorax 2004;59:808–17.
  • Plowman EK, Tabor-Gray L, Rosado KM, Vasilopoulos T, Robison R, Chapin JL, et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham-controlled trial. Muscle Nerve. 2019;59:40–6. Epub 2018 Nov 29. PMID: 29981250.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.